Skip to Main Content

Paper Details

Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers.
Gynecol Oncol
31
2017
ER, PDX, PDX tumor models, Patients, estrogen, estrogen receptor, estrogen receptor-positive ovarian, everolimus, high-grade ovarian cancer, letrozole, ovarian tumors, patient, patients, platinum, primary peritoneal carcinomas, relapsed, tumor, tumors
Author NameAffiliation
Saravut J WerohaMayo Clinic
Paul HaluskaMayo Clinic
John A CoplandMayo Clinic
John A CoplandMayo Clinic
  • 1 - 4

Datasets

Release 1.2